...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zrnith- Exempt Distribution

Dated:  23/03/22

Out of: USA, Germany

300,000 CS + warrant @ $1.26 = $378,000.00 CAN

Warrant: $1.26 Expires 2027-03-23

 

Koo

Share
New Message
Please login to post a reply